Deltex Medical Group plc
DEMG.L · LSE
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -£1,257 | -£1,149 | -£967 | -£798 |
| Dep. & Amort. | £133 | £128 | £114 | £143 |
| Deferred Tax | £0 | -£180 | £105 | £65 |
| Stock-Based Comp. | £0 | £125 | £95 | £39 |
| Change in WC | -£232 | £208 | £434 | £379 |
| Other Non-Cash | £161 | £262 | -£72 | £104 |
| Operating Cash Flow | -£1,195 | -£606 | -£291 | -£68 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£9 | -£744 | -£644 | -£171 |
| Net Acquisitions | £0 | £0 | £0 | £0 |
| Inv. Purchases | £0 | £0 | £0 | £0 |
| Inv. Sales/Matur. | £0 | £0 | £0 | £0 |
| Other Inv. Act. | -£361 | -£674 | -£621 | -£165 |
| Investing Cash Flow | -£370 | -£744 | -£644 | -£171 |
| Financing Activities | – | – | – | – |
| Debt Repay. | £144 | £233 | -£41 | -£23 |
| Stock Issued | £1,887 | £1,340 | £0 | £253 |
| Stock Repurch. | £0 | £0 | £0 | £0 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | -£245 | -£160 | £543 | -£40 |
| Financing Cash Flow | £1,786 | £1,413 | £502 | £190 |
| Forex Effect | £13 | -£5 | -£7 | -£6 |
| Net Chg. in Cash | £234 | £58 | -£440 | -£55 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £471 | £413 | £853 | £908 |
| End Cash | £705 | £471 | £413 | £853 |
| Free Cash Flow | -£1,565 | -£1,350 | -£935 | -£239 |